A state appeals court tossed a $25 million verdict against Hoffmann-La Roche in a suit over acne drug Accutane after finding that the trial judge improperly restricted duplicative testimony from two defense experts.

On Tuesday the panel ordered a new trial for Andrew McCarrell, who developed inflammatory bowel disease and had to have his bowel and colon surgically removed as a result of using Accutane. During McCarrell’s 2010 trial, Roche sought to present overlapping opinions from an epidemiologist and a gastroenterologist on the merits of certain studies, but the late Superior Court Judge Carol Higbee, who was presiding, told counsel she would not allow testimony from multiple experts with similar opinions, and only testimony from the gastroenterologist was presented.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]